Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Does heart failure confer a hypercoagulable state? Virchow's triad revisited.

G Y Lip1, C R Gibbs

  • 1University Department of Medicine, City Hospital, Birmingham, United Kingdom.G.Y.H.LIP@bham.ac.uk

Journal of the American College of Cardiology
|April 8, 1999
PubMed
Summary

Patients with heart failure face a higher risk of stroke and blood clots due to abnormal blood flow, vessel walls, and clotting factors. Further research is needed to identify high-risk individuals and optimize antithrombotic therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

State of play and future direction with NOACs: An expert consensus.

Vascular pharmacology·2018
Same author

Glycative and oxidative stress are associated with altered thrombus composition in diabetic patients with ST-elevation myocardial infarction.

International journal of cardiology·2017
Same author

Reply to Jolobe

The journal of the Royal College of Physicians of Edinburgh·2017
Same author

Clinical Stroke prevention in atrial fibrillation.

The journal of the Royal College of Physicians of Edinburgh·2017
Same author

Short runs of atrial arrhythmia and stroke risk: a European-wide online survey among stroke physicians and cardiologists.

The journal of the Royal College of Physicians of Edinburgh·2016
Same author

'Patient choice' concept in AF ESC Guidelines: is the clinician giving up? Reply.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2013

Area of Science:

  • Cardiology
  • Hematology
  • Vascular Medicine

Background:

  • Congestive heart failure (CHF) patients have increased risk of stroke and venous thromboembolism.
  • Thrombotic events are often underestimated in CHF trials, potentially masking a significant problem.
  • Pathophysiology of thrombogenesis in CHF aligns with Virchow's triad: abnormal flow, vessel wall issues, and hemostatic abnormalities.

Purpose of the Study:

  • To highlight the underestimated significance of thrombosis in heart failure.
  • To explore the pathophysiological mechanisms contributing to a hypercoagulable state in CHF.
  • To review current evidence and identify gaps in antithrombotic therapy for CHF patients.

Main Methods:

  • Review of existing literature on thrombogenesis in heart failure.

Related Experiment Videos

  • Analysis of pathophysiological mechanisms based on Virchow's triad.
  • Evaluation of current evidence for antithrombotic therapy in CHF.

    • Main Results:

    • CHF patients exhibit a prothrombotic state due to impaired cardiac function, endothelial dysfunction, and hemostatic abnormalities.
    • Antithrombotic therapy is supported in CHF with atrial fibrillation, but evidence for sinus rhythm patients is limited.
    • Large-scale trials on antithrombotic therapy in sinus rhythm CHF patients are ongoing.

    Conclusions:

    • Thrombogenesis is a significant, potentially underestimated, issue in heart failure.
    • Identifying high-risk patients and optimizing antithrombotic treatments require further investigation.
    • Markers of thrombogenesis and hypercoagulability need further study in CHF populations.